Liberum Biotech
The Protein Discovery Company
The Protein Discovery Company
Liberum Biotech is a seed-stage venture that focuses on accelerating enzyme and antibody discovery through its cutting-edge proprietary cell-free protein synthesis platform. Founded in 2019, it operates within the biotechnology and manufacturing industries. The company recently secured a significant $1.80M Seed Round investment on 24 July 2023 from prominent investors such as SOSV, TechU Ventures, and Savantus Ventures. With its forward-looking approach and innovative technology, Liberum Biotech, also known as "The Protein Discovery Company," is poised to make a profound impact in the biotech industry landscape.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.80M | 3 |
|
24 Jul 2023 |
| Non Equity Assistance | Unknown | 1 |
|
01 Jan 2021 |
| Pre Seed Round | Unknown | 1 |
|
12 Aug 2020 |
| Pre Seed Round | Unknown | 1 |
|
01 Jan 2019 |
No recent news or press coverage available for Liberum Biotech.
We care about your data, and we'd love to use cookies make your experience better.
